FENNEC PHARMACEUTICALS INC.
Prevents chemotherapy-induced hearing loss in children with its sole product, PEDMARK®.
FENC | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- PO BOX 13628, 27709 RESEARCH TRIANGLE PARK
- Website:
- https://fennecpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Fennec Pharmaceuticals Inc. is a commercial-stage specialty biopharmaceutical company focused on the development and commercialization of its sole product, PEDMARK®. PEDMARK®, a unique formulation of sodium thiosulfate, is designed to prevent ototoxicity (hearing loss) in pediatric patients who are receiving platinum-based chemotherapy, such as cisplatin. The company is dedicated to addressing this specific unmet medical need to improve the quality of life for children undergoing cancer treatment by mitigating the long-term, debilitating side effects of chemotherapy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all FENNEC PHARMACEUTICALS INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for FENNEC PHARMACEUTICALS INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for FENNEC PHARMACEUTICALS INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
